Eclipsebio is excited to announce the launch of eMERGE, our end-to-end platform for the characterization and optimization of RNA medicines!
Obtaining all the data and analyses needed for the successful development of an RNA-based vaccine or therapeutic is extremely challenging. As part of eMERGE, our partners obtain the insights needed for successful therapeutic development through exclusive access to our suite of cutting-edge technologies and bioinformatics workflows. Discover how we robustly identify ribosome stalls that can lead to frameshifts, measure stability-influencing structure directly within LNPs, and more.
Click the link below to learn more and contact us today to obtain the support needed for successful vaccine and therapeutic development!
https://t.co/gDQZBOhBWX
#rnatherapeutics #RNA